Robert Powell - Fresenius Medical Member AG
| 0H9X Stock | 42.08 0.70 1.64% |
Executive
Robert Powell is Member AG of Fresenius Medical Care
| Age | 69 |
| Address | Else-KrOener-Strasse 1, Bad Homburg, Germany, 61352 |
| Phone | 49 6172 609 0 |
| Web | https://www.freseniusmedicalcare.com |
Fresenius Medical Management Efficiency
The company has return on total asset (ROA) of 0.0298 % which means that it generated a profit of $0.0298 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0582 %, meaning that it generated $0.0582 on every $100 dollars invested by stockholders. Fresenius Medical's management efficiency ratios could be used to measure how well Fresenius Medical manages its routine affairs as well as how well it operates its assets and liabilities. Total Assets is likely to drop to about 30.9 B in 2024. Other Assets is likely to drop to about 1.1 B in 2024Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| John Hutt | Ameriprise Financial | 48 | |
| Dimitrios Dimopoulos | National Bank of | 77 | |
| Margaret Keane | Synchrony Financial | 65 | |
| Thomas CPA | Monster Beverage Corp | 70 | |
| Michael Bopp | Synchrony Financial | 50 | |
| Stephen Crawford | Eastman Chemical Co | 59 | |
| Adrian Holt | Eastman Chemical Co | 55 | |
| Alicia Charity | Ameriprise Financial | N/A | |
| Carol Juel | Synchrony Financial | 51 | |
| Peter Schnellmann | Cembra Money Bank | 51 | |
| Heather Melloh | Ameriprise Financial | 52 | |
| Jonathan Esq | Synchrony Financial | 60 | |
| Bart Schaller | Synchrony Financial | 54 | |
| Georgios Triantafillakis | National Bank of | 67 | |
| PanagiotisIoannis Dasmanoglou | National Bank of | 61 | |
| Eric Anliker | Cembra Money Bank | 56 | |
| Kelli Petruzillo | Ameriprise Financial | 63 | |
| Volker Gloe | Cembra Money Bank | 56 | |
| Charles Gibb | Fevertree Drinks Plc | N/A | |
| Christian Schmitt | Cembra Money Bank | N/A | |
| Vasilis Karamouzis | National Bank of | 47 | |
Management Performance
| Return On Equity | 0.0582 | ||||
| Return On Asset | 0.0298 |
Fresenius Medical Care Leadership Team
Elected by the shareholders, the Fresenius Medical's board of directors comprises two types of representatives: Fresenius Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius Medical's management team and ensure that shareholders' interests are well served. Fresenius Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Oliver Maier, Senior Relations | ||
| Helen Giza, Chief CEO | ||
| Roberto Fuste, Executive Strategy | ||
| Nwamaka MD, Head Operations | ||
| GailSuzanne Brown, Senior Development | ||
| Katarzyna MazurHofsab, Management AG | ||
| Borries Muller, Senior Communications | ||
| FACHE MBA, CEO Board | ||
| Joachim Weith, Senior Affairs | ||
| Robert Powell, Member AG | ||
| Franklin FACP, Global Board | ||
| Dominik Heger, Strategic Relations | ||
| Martin Fischer, CFO Board | ||
| Glenn Slater, Senior Operations | ||
| William Valle, Management AG | ||
| Jorg Haring, Compliance Legal | ||
| Wolfgang Kummerle, Senior International |
Fresenius Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Fresenius Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0582 | ||||
| Return On Asset | 0.0298 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 23.52 B | ||||
| Shares Owned By Insiders | 32.16 % | ||||
| Shares Owned By Institutions | 38.80 % | ||||
| Revenue | 19.24 B | ||||
| Gross Profit | 5.31 B | ||||
| EBITDA | 2.42 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.